ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,078, issued on July 7, was assigned to ETH Zurich (Zurich, Switzerland).
"Bacteriophages producing heterologous bacteriocins" was invented by Samuel Nando Kilcher (Zurich, Switzerland), Matthew Stephen Dunne (Zurich, Switzerland), Susanne Andrea Meile (Zurich, Switzerland), Jiemin Du (Zurich, Switzerland) and Martin Johannes Loessner (Zurich, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of medicine, specifically the field of bacterial infection and treatment thereof."
The patent was filed on June 30, 2023, under Application No. 18/344,998.
*For further information, including images, charts an...